These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33125196)

  • 21. Immunogenicity of Adalimumab in Patients with Non-Infectious Uveitis: Systematic Review and Meta-Analysis.
    Pachón-Suárez DI; Zárate-Pinzón L; Cifuentes-González C; Rojas-Carabali W; Mejía-Salgado G; Pineda JS; Peña-Pulgar LF; de-la-Torre A
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1539-1548. PubMed ID: 37796609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the systemic management of noninfectious uveitis in children and adolescents.
    Leal I; Steeples LR; Wong SW; Giuffrè C; Pockar S; Sharma V; Green EKY; Payne J; Jones NP; Chieng ASE; Ashworth J
    Surv Ophthalmol; 2024; 69(1):103-121. PubMed ID: 36682467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.
    Mercier AE; Ribeiro E; Korobelnik JF; Delyfer MN; Rougier MB
    Ocul Immunol Inflamm; 2018; 26(3):477-484. PubMed ID: 27775458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.
    Lee JT; Yates WB; Rogers S; Wakefield D; McCluskey P; Lim LL
    Br J Ophthalmol; 2018 Dec; 102(12):1672-1678. PubMed ID: 29459430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Knowledge of Biologics in Treatment of Noninfectious Uveitis.
    Gupta S; Shyamsundar K; Agrawal M; Vichare N; Biswas J
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):203-222. PubMed ID: 35133890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
    Fabiani C; Vitale A; Emmi G; Bitossi A; Lopalco G; Sota J; Guerriero S; Orlando I; Capozzoli M; Fusco F; Rana F; Iannone F; Frediani B; Galeazzi M; Vannozzi L; Tosi GM; Cantarini L
    Clin Rheumatol; 2019 Jan; 38(1):63-70. PubMed ID: 29611087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current standardized therapeutic approach for uveitis in Japan.
    Maruyama K
    Immunol Med; 2019 Sep; 42(3):124-134. PubMed ID: 31645201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recalcitrant psoriatic uveitis and anti-tumor necrosis factor-α monoclonal antibodies: experience from a psoriasis referral center.
    Fotiadou C; Lazaridou E; Kemanetzi C; Kyrmanidou E; Ioannides D
    Int J Dermatol; 2015 Sep; 54(9):1105-8. PubMed ID: 25557117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expert opinion on the use of biological therapy in non-infectious uveitis.
    Touhami S; Diwo E; Sève P; Trad S; Bielefeld P; Sène D; Abad S; Brézin A; Quartier P; Koné Paut I; Weber M; Chiquet C; Errera MH; Sellam J; Cacoub P; Kaplanski G; Kodjikian L; Bodaghi B; Saadoun D
    Expert Opin Biol Ther; 2019 May; 19(5):477-490. PubMed ID: 30888881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and current therapies for non-infectious uveitis.
    Wu X; Tao M; Zhu L; Zhang T; Zhang M
    Clin Exp Med; 2023 Aug; 23(4):1089-1106. PubMed ID: 36422739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review.
    Rosenbaum JT; Bodaghi B; Couto C; Zierhut M; Acharya N; Pavesio C; Tay-Kearney ML; Neri P; Douglas K; Pathai S; Song AP; Kron M; Foster CS
    Semin Arthritis Rheum; 2019 Dec; 49(3):438-445. PubMed ID: 31301816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan.
    Hwang DK; Hwang YS; Tsai ML; Lin CJ; Chan WC; Chang YC; Chen DY; Hsieh TY; Sheu SJ; Lin CP
    Taiwan J Ophthalmol; 2018; 8(3):117-120. PubMed ID: 30294525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital.
    Petropoulos IK; Vaudaux JD; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2008 May; 225(5):457-61. PubMed ID: 18454398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.
    Lee S; Park YJ; Lee JY
    J Korean Med Sci; 2019 Nov; 34(42):e278. PubMed ID: 31674159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete blood count parameters and neutrophil-to-lymphocyte ratio values as markers for differentiation between systemic infectious and non-infectious uveitis.
    Yildiz Balci S; Turan-Vural E; Turkyilmaz O; Esen F; Aksaray S
    Int Ophthalmol; 2020 Nov; 40(11):3033-3041. PubMed ID: 32617803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Pharmacological Strategies for the Treatment of Non-Infectious Uveitis. A Minireview.
    Valenzuela RA; Flores I; Urrutia B; Fuentes F; Sabat PE; Llanos C; Cuitino L; Urzua CA
    Front Pharmacol; 2020; 11():655. PubMed ID: 32508634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Systemic biological treatment in ophthalmology].
    Benyó F; Farkas A; Horváth H; Nagy ZZ; Szepessy Z
    Orv Hetil; 2019 Nov; 160(44):1744-1750. PubMed ID: 31657252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspectives for immunotherapy in noninfectious immune mediated uveitis.
    Touhami S; Gueudry J; Leclercq M; Touitou V; Ghembaza A; Errera MH; Saadoun D; Bodaghi B
    Expert Rev Clin Immunol; 2021 Sep; 17(9):977-989. PubMed ID: 34264142
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.
    Busto-Iglesias M; Rodríguez-Martínez L; Rodríguez-Fernández CA; González-López J; González-Barcia M; de Domingo B; Rodríguez-Rodríguez L; Fernández-Ferreiro A; Mondelo-García C
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.